HY-100877-1mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
HY-100877-10mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
HY-100877-100mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
HY-100877-25mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
HY-100877-5mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
HY-100877-50mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
HY-101027A-10mg
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2]
|
|
Cancer-programmed cell death
|
|
HY-101027A-100mg
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2]
|
|
Cancer-programmed cell death
|
|
HY-101027A-25mg
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2]
|
|
Cancer-programmed cell death
|
|
HY-101027A-5mg
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2]
|
|
Cancer-programmed cell death
|
|
HY-101027A-50mg
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2]
|
|
Cancer-programmed cell death
|
|
HY-100877-1mL
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-101027A-1mL
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|